BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Conlon N, Soslow RA, Murali R. Perivascular epithelioid tumours (PEComas) of the gynaecological tract. J Clin Pathol 2015;68:418-26. [PMID: 25750268 DOI: 10.1136/jclinpath-2015-202945] [Cited by in Crossref: 59] [Cited by in F6Publishing: 59] [Article Influence: 7.4] [Reference Citation Analysis]
Number Citing Articles
1 Anderson WJ, Dong F, Fletcher CDM, Hirsch MS, Nucci MR. A Clinicopathologic and Molecular Characterization of Uterine Sarcomas Classified as Malignant PEComa. Am J Surg Pathol 2023. [PMID: 36856023 DOI: 10.1097/PAS.0000000000002028] [Reference Citation Analysis]
2 Jiang Y, Liu X, Zhang S, Wang Q, Xu Q, Ghias K, Cao L. Risk stratification and outcomes in 210 gynecologic perivascular epithelioid cell tumors (PEComas) cases. Arch Gynecol Obstet 2023;307:681-7. [PMID: 35411411 DOI: 10.1007/s00404-022-06470-y] [Reference Citation Analysis]
3 Yamada K, Yamanishi Y, Aratake J, Sasagasako N, Inayama Y, Gou R, Kawamura A, Yamanishi M, Kosaka K. A Case of Uterine Lymphangioleiomyomatosis Complicated by Tuberous Sclerosis Complex. Case Rep Obstet Gynecol 2022;2022:2893975. [PMID: 36561726 DOI: 10.1155/2022/2893975] [Reference Citation Analysis]
4 Sadeghi N, Smyth S, Damato S, Soleymani Majd H. Perivascular epithelioid cell tumour and investigation of genetic susceptibility. BMJ Case Rep 2022;15:e250460. [PMID: 36450410 DOI: 10.1136/bcr-2022-250460] [Reference Citation Analysis]
5 Arciuolo D, Travaglino A, Santoro A, Raffone A, Pedone Anchora L, Fanfani F, Inzani F, Zannoni GF. Endometrial carcinoma with diffuse melanocytic differentiation: Clinicopathological and molecular analysis of a case with literature review and focus on differential diagnosis. Pathol Res Pract 2022;238:154122. [PMID: 36174440 DOI: 10.1016/j.prp.2022.154122] [Reference Citation Analysis]
6 Lanchinsky VI, Chushkov YV, Ponomarev AB, Osmanov YI, Ishchenko AI, Vorobev NV. The problem of rare tumors in gynecology: a clinical case of benign retroperitoneal sclerosing pelvic pecoma in 49-year-old woman. Issled prakt med (Print) 2022;9:113-124. [DOI: 10.17709/2410-1893-2022-9-2-10] [Reference Citation Analysis]
7 Zhang Z, Yu Y, Zhang L, Cheng C, Zuo C. 18F-FDG and 68Ga-FAPI-04 in the Evaluation of Aggressive Perivascular Epithelioid Cell Tumor. Clin Nucl Med 2022. [PMID: 35485860 DOI: 10.1097/RLU.0000000000004249] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Soslow RA. Melanocytic marker expression and TSC alterations/TFE3 fusions in uterine PEComas. Mod Pathol 2022;35:449-50. [PMID: 35046524 DOI: 10.1038/s41379-021-01004-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Chiang S, Vasudevaraja V, Serrano J, Stewart CJR, Oliva E, Momeni-Boroujeni A, Jungbluth AA, Da Cruz Paula A, da Silva EM, Weigelt B, Park KJ, Soslow RA, Murali R, Ellenson LH, Benayed R, Ladanyi M, Abu-Rustum NR, Dickson MA, Cohen S, Aghajanian C, Hensley ML, Lee CH, Snuderl M, Konner JA. TSC2-mutant uterine sarcomas with JAZF1-SUZ12 fusions demonstrate hybrid features of endometrial stromal sarcoma and PEComa and are responsive to mTOR inhibition. Mod Pathol 2022;35:117-27. [PMID: 34561551 DOI: 10.1038/s41379-021-00922-7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
10 Grifone TJ, Crum CP. Uterus. Handbook of Practical Immunohistochemistry 2022. [DOI: 10.1007/978-3-030-83328-2_20] [Reference Citation Analysis]
11 Muniraj F, Divyapriya C, Raghavan V, Radha RKN, Ramanujam S, Rajakumar SA. Cervical Angiomyolipoma Coexisting with Endometrial Carcinoma in the Absence of Tuberous Sclerosis: A Rare Case Report. Indian J Med Paediatr Oncol 2021;42:305-8. [DOI: 10.1055/s-0041-1733822] [Reference Citation Analysis]
12 Naveed S, Zahoor S, Batoo AJ, Haji AG, Mir AW, Qazi IA. Perivascular Epithelioid Cell Tumor (PEComa) of Vulva: a Rare Occurrence. Indian J Surg Oncol. [DOI: 10.1007/s13193-021-01437-y] [Reference Citation Analysis]
13 McBride A, Garcia AJ, Sanders LJ, Yiu K, Cranmer LD, Kuo PH, Kay M, Kraft AS. Sustained response to pembrolizumab in recurrent perivascular epithelioid cell tumor with elevated expression of programmed death ligand: a case report. J Med Case Rep 2021;15:400. [PMID: 34301321 DOI: 10.1186/s13256-021-02997-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
14 Shukla PS, Xia R, Lin LH, Schwartz CJ. Gynaecological perivascular epithelioid cell tumour (PEComa): comparative analysis of proposed algorithms for prediction of clinical outcome. Histopathology 2021. [PMID: 34157139 DOI: 10.1111/his.14434] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
15 Valencia-Guerrero A, Pinto A, Anderson WJ, Trevisan G, Nucci MR, Hirsch MS. PNL2: A Useful Adjunct Biomarker to HMB45 in the Diagnosis of Uterine Perivascular Epithelioid Cell Tumor (PEComa). Int J Gynecol Pathol 2020;39:529-36. [PMID: 31851063 DOI: 10.1097/PGP.0000000000000653] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
16 Liapi A, Mathevet P, Herrera FG, Hastir D, Sarivalasis A. VEGFR Inhibitors for Uterine Metastatic Perivascular Epithelioid Tumors (PEComa) Resistant to mTOR Inhibitors. A Case Report and Review of Literature. Front Oncol 2021;11:641376. [PMID: 33842348 DOI: 10.3389/fonc.2021.641376] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
17 Houcine Y, Mekni K, Brahem E, Mlika M, Ayadi A, Fekih C, Ridene I, El Mezni F. A case of perivascular epithelioid nodules arising in an intramural leiomyoma. Human Pathology: Case Reports 2021;23:200470. [DOI: 10.1016/j.ehpc.2020.200470] [Reference Citation Analysis]
18 Wang J, Yang Q, Zhang N, Wang D. Uterine angiomyolipoma: a clinical analysis of 8 cases and literature review. Arch Gynecol Obstet 2021;304:171-7. [PMID: 33569612 DOI: 10.1007/s00404-021-05992-1] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
19 Euscher ED, Buza N, Hui P. Immunohistochemistry. Practical Gynecologic Pathology 2021. [DOI: 10.1007/978-3-030-68608-6_15] [Reference Citation Analysis]
20 Xing D, Fischer JV, Liu J. Inherited Cancer Syndromes. Practical Gynecologic Pathology 2021. [DOI: 10.1007/978-3-030-68608-6_14] [Reference Citation Analysis]
21 Stewart CJR, McCluggage WG, Chua YJ, Texler M, Rabban JT. Uterine plexiform tumourlets: multifocal and solitary cases with subsets expressing melanocytic markers. Histopathology 2021;78:690-8. [PMID: 33103268 DOI: 10.1111/his.14274] [Reference Citation Analysis]
22 Bennett JA, Oliva E. Perivascular epithelioid cell tumors (PEComa) of the gynecologic tract. Genes Chromosomes Cancer 2021;60:168-79. [PMID: 33099813 DOI: 10.1002/gcc.22908] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
23 Nguyen JMV, Ghandehari H, Parra-herran C, Vicus D. Uterine rupture: an unusual presentation of a uterine perivascular epithelioid cell tumor (PEComa). Int J Gynecol Cancer 2020;30:2008-11. [DOI: 10.1136/ijgc-2020-001837] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
24 Gadducci A, Zannoni GF. Perivascular epithelioid cell tumors (PEComa) of the female genital tract: A challenging question for gynaecologic oncologist and pathologist. Gynecol Oncol Rep 2020;33:100603. [PMID: 32685651 DOI: 10.1016/j.gore.2020.100603] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
25 Kord A, Eppurath A, Drammeh H, Elbaz Younes I, Xie KL. SMARCA4-deficient uterine sarcoma: A case report and a concise review. Case Rep Womens Health 2020;27:e00231. [PMID: 32551237 DOI: 10.1016/j.crwh.2020.e00231] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
26 Hirsch MS, Watkins J. A Comprehensive Review of Biomarker Use in the Gynecologic Tract Including Differential Diagnoses and Diagnostic Pitfalls. Adv Anat Pathol 2020;27:164-92. [PMID: 31149908 DOI: 10.1097/PAP.0000000000000238] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
27 Karunanithi J, Busmanis I. Surprise Lymph Node Histology in a Patient with Ovarian Serous Carcinoma. Case Rep Obstet Gynecol 2020;2020:6468124. [PMID: 32095299 DOI: 10.1155/2020/6468124] [Reference Citation Analysis]
28 Soulié P, Barra CC. PEComas: An Uncommon Family of Sarcomas Sensitive to Targeted Therapy. Rare Sarcomas 2020. [DOI: 10.1007/978-3-030-24697-6_3] [Reference Citation Analysis]
29 Malpica A, Euscher ED, Ramalingam P, Aguilera-barrantes I, Alvarado-cabrero I. Gynecological Pathology. Oncological Surgical Pathology 2020. [DOI: 10.1007/978-3-319-96681-6_15] [Reference Citation Analysis]
30 Parra-herran C. Mesenchymal and Miscellaneous Lesions of the Uterus. Gynecologic Pathology 2020. [DOI: 10.1016/b978-0-323-35909-2.00011-4] [Reference Citation Analysis]
31 Au RTM, Ahmed ADB, Ho BCS, Teo CHY, Chuah KL. Malignant Pleural PEComa: A Previously Undocumented Site. Int J Surg Pathol 2020;28:549-52. [PMID: 31865805 DOI: 10.1177/1066896919893074] [Reference Citation Analysis]
32 Parra-Herran C, Howitt BE. Uterine Mesenchymal Tumors: Update on Classification, Staging, and Molecular Features. Surg Pathol Clin 2019;12:363-96. [PMID: 31097109 DOI: 10.1016/j.path.2019.01.004] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 7.0] [Reference Citation Analysis]
33 Leathersich S, Koay MHE, Khani A, Malla Bhat S. Isolated sporadic uterine lymphangioleiomyoma with unusual clinical and pathological features. BMJ Case Rep 2019;12:e231683. [PMID: 31704800 DOI: 10.1136/bcr-2019-231683] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
34 Oliva E, Zaloudek CJ, Soslow RA. Mesenchymal Tumors of the Uterus. In: Kurman RJ, Hedrick Ellenson L, Ronnett BM, editors. Blaustein's Pathology of the Female Genital Tract. Cham: Springer International Publishing; 2019. pp. 535-647. [DOI: 10.1007/978-3-319-46334-6_10] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
35 Rothenberger R, Jackson A, Kendler A, Herzog T, Billingsley C. An unusual case of uterine PEComa presenting with disseminated intravascular coagulation. Gynecol Oncol Rep 2019;29:76-8. [PMID: 31384655 DOI: 10.1016/j.gore.2019.06.007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
36 Grant L, Chipwete S, Soo Hoo S, Bhatnagar A. Extrapulmonary uterine lymphangioleiomyomatosis (LAM) and dysfunctional uterine bleeding: the first presentation of LAM in a tuberous sclerosis complex patient. BMJ Case Rep 2019;12:e226358. [PMID: 30804158 DOI: 10.1136/bcr-2018-226358] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
37 Caliò A, Segala D, Martignoni G. ♂♀Mesenchymal Tumors of the Kidney. Gynecologic and Urologic Pathology 2019. [DOI: 10.1017/9781316756423.020] [Reference Citation Analysis]
38 Howitt BE, Nucci MR. Uterine Mesenchymal Lesions. Gynecologic and Obstetric Pathology, Volume 2 2019. [DOI: 10.1007/978-981-13-3019-3_1] [Reference Citation Analysis]
39 Murdock TA, Veras EFT, Kurman RJ, Mazur MT. Mesenchymal Tumors and Other Rare Neoplasms. Diagnosis of Endometrial Biopsies and Curettings 2019. [DOI: 10.1007/978-3-319-98608-1_11] [Reference Citation Analysis]
40 Fetsch JF, Laskin WB. Soft Tissue Lesions Involving Female Reproductive Organs. Blaustein's Pathology of the Female Genital Tract 2019. [DOI: 10.1007/978-3-319-46334-6_22] [Reference Citation Analysis]
41 Liu CH, Chao WT, Lin SC, Lau HY, Wu HH, Wang PH. Malignant perivascular epithelioid cell tumor in the female genital tract: Preferred reporting items for systematic reviews and meta-analyses. Medicine (Baltimore) 2019;98:e14072. [PMID: 30633211 DOI: 10.1097/MD.0000000000014072] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
42 Rekhtman N, Baine MK, Bishop JA. Grading (and Classification) Systems Quick Reference: Solid Tumors. Quick Reference Handbook for Surgical Pathologists 2019. [DOI: 10.1007/978-3-319-97508-5_8] [Reference Citation Analysis]
43 Shan W, Shi Y, Zhu Q, Yang B, Xie L, Li B, Ning C, Lv Q, Cheng Y, Xie B, Bai M, Xu Y, Chen X, Luo X. Five cases of uterine perivascular epithelioid cell tumors (PEComas) and review of literature. Arch Gynecol Obstet 2019;299:185-90. [PMID: 30317387 DOI: 10.1007/s00404-018-4920-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
44 Kolin DL, Dong F, Baltay M, Lindeman N, MacConaill L, Nucci MR, Crum CP, Howitt BE. SMARCA4-deficient undifferentiated uterine sarcoma (malignant rhabdoid tumor of the uterus): a clinicopathologic entity distinct from undifferentiated carcinoma. Mod Pathol 2018;31:1442-56. [PMID: 29700418 DOI: 10.1038/s41379-018-0049-z] [Cited by in Crossref: 100] [Cited by in F6Publishing: 101] [Article Influence: 20.0] [Reference Citation Analysis]
45 Tynski Z, Chiang W, Barrett A. An Inguinal Perivascular Epithelioid Cell Tumor Metastatic to the Orbit. Case Rep Pathol 2018;2018:5749421. [PMID: 30002939 DOI: 10.1155/2018/5749421] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
46 Westaby JD, Magdy N, Fisher C, El-Bahrawy M. Primary Ovarian Malignant PEComa: A Case Report. Int J Gynecol Pathol 2017;36:400-4. [PMID: 27684885 DOI: 10.1097/PGP.0000000000000331] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
47 Wilkinson N, Griffin NR. Problematic areas and new developments in uterine mesenchymal tumours. Diagnostic Histopathology 2018;24:32-44. [DOI: 10.1016/j.mpdhp.2017.11.014] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
48 Oliva E, Zaloudek CJ, Soslow RA. Mesenchymal Tumors of the Uterus. Blaustein's Pathology of the Female Genital Tract 2018. [DOI: 10.1007/978-1-4614-3165-7_10-2] [Reference Citation Analysis]
49 Howitt BE, Nucci MR, Quade BJ. Uterine Mesenchymal Tumors. Diagnostic Gynecologic and Obstetric Pathology 2018. [DOI: 10.1016/b978-0-323-44732-4.00020-0] [Reference Citation Analysis]
50 Fetsch JF, Laskin WB. Soft Tissue Lesions Involving Female Reproductive Organs. Blaustein's Pathology of the Female Genital Tract 2018. [DOI: 10.1007/978-1-4614-3165-7_22-2] [Reference Citation Analysis]
51 Okamoto S, Komura M, Terao Y, Kurisaki-Arakawa A, Hayashi T, Saito T, Togo S, Shiokawa A, Mitani K, Kobayashi E, Kumasaka T, Takahashi K, Seyama K. Pneumothorax caused by cystic and nodular lung metastases from a malignant uterine perivascular epithelioid cell tumor (PEComa). Respir Med Case Rep 2017;22:77-82. [PMID: 28706850 DOI: 10.1016/j.rmcr.2017.06.011] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
52 Howitt BE, Nucci MR. Molecular Pathology of Uterine Mesenchymal Tumors. Molecular Pathology Library 2017. [DOI: 10.1007/978-3-319-57985-6_11] [Reference Citation Analysis]
53 Theofanakis C, Thomakos N, Sotiropoulou M, Rodolakis A. Perivascular epithelioid cell tumor of the uterus: Report of two cases and mini-review of the literature. Int J Surg Case Rep 2016;28:85-7. [PMID: 27689526 DOI: 10.1016/j.ijscr.2016.09.017] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
54 Padhi P, Rali P, Hattab Y, Adjapong O, Malik KJ, Mao S. WITHDRAWN: A Unique Case of Perivascular Epithelioid Cell Tumor Associated With Birt-Hogg-Dube Syndrome. Clin Genitourin Cancer 2016:S1558-7673(16)30203-8. [PMID: 29079164 DOI: 10.1016/j.clgc.2016.07.002] [Reference Citation Analysis]
55 Fitzpatrick M, Pulver T, Klein M, Murugan P, Khalifa M, Amin K. Perivascular Epithelioid Cell Tumor of the Uterus with Ovarian Involvement: A Case Report and Review of the Literature. Am J Case Rep 2016;17:309-14. [PMID: 27150246 DOI: 10.12659/ajcr.896401] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
56 Kudela E, Biringer K, Kasajova P, Nachajova M, Adamkov M. Perivascular epithelioid cell tumors of the uterine cervix. Pathol Res Pract. 2016;212:667-671. [PMID: 27083240 DOI: 10.1016/j.prp.2016.03.010] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
57 Perivascular Epithelioid Cell Tumor (PEComa). Diagnostic Pathology: Soft Tissue Tumors 2016. [DOI: 10.1016/b978-0-323-37675-4.50177-0] [Reference Citation Analysis]
58 PEComa. Diagnostic Pathology: Vascular 2016. [DOI: 10.1016/b978-0-323-37674-7.50138-0] [Reference Citation Analysis]
59 Oliva E. Practical issues in uterine pathology from banal to bewildering: the remarkable spectrum of smooth muscle neoplasia. Mod Pathol 2016;29 Suppl 1:S104-20. [PMID: 26715170 DOI: 10.1038/modpathol.2015.139] [Cited by in Crossref: 55] [Cited by in F6Publishing: 56] [Article Influence: 7.9] [Reference Citation Analysis]
60 Soslow RA, Oliva E. Uterine Cancer: Pathology. Current Clinical Oncology 2015. [DOI: 10.1007/7631_2015_7] [Reference Citation Analysis]